Antihormonal Cancer Therapies Market
The global Antihormonal Cancer Therapies market size was valued at US$ 12.34 billion in 2024 and is projected to reach US$ 17.89 billion by 2030, at a CAGR of 6.4% during the forecast period 2024-2030.
United States Antihormonal Cancer Therapies market size was valued at US$ 3.34 billion in 2024 and is projected to reach US$ 4.67 billion by 2030, at a CAGR of 5.7% during the forecast period 2024-2030.
Treatments that block or lower the levels of hormones to stop or slow the growth of cancer.
Report Overview
Antihormonal Cancer Therapy is a treatment with drugs, surgery, or radiation in order to block the production or action of a hormone. Antihormone therapy may be used in cancer treatment because certain hormones are able to stimulate the growth of some types of tumors.
This report provides a deep insight into the global Antihormonal Cancer Therapies market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Antihormonal Cancer Therapies Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Antihormonal Cancer Therapies market in any manner.
Global Antihormonal Cancer Therapies Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
- Roche
- Amgen
- Samyang Biopharmaceuticals
- Tolmar
- Bluebird Bio
- Bristol-Myers Squibb
- Exelixis
- Guardant Health
- Illumina
- Novartis
- Merck KGaA
- AbbVie
- Gilead Sciences
- Johnson & Johnson
- Pfizer
- Takeda
- Eli Lilly
- AstraZeneca
- Astellas
- Merck & Co.
- Sanofi
- Bayer
Market Segmentation (by Type)
- Radiations
- Drugs
- Surgeries
- Others
Market Segmentation (by Application)
- Breast Cancer
- Prostate Cancer
- Other
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Antihormonal Cancer Therapies Market
- Overview of the regional outlook of the Antihormonal Cancer Therapies Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value (USD Billion) data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the
major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Antihormonal Cancer Therapies
1.2 Key Market Segments
1.2.1 Antihormonal Cancer Therapies Segment by Type
1.2.2 Antihormonal Cancer Therapies Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Antihormonal Cancer Therapies Market Overview
2.1 Global Market Overview
2.1.1 Global Antihormonal Cancer Therapies Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Antihormonal Cancer Therapies Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Antihormonal Cancer Therapies Market Competitive Landscape
3.1 Global Antihormonal Cancer Therapies Sales by Manufacturers (2019-2024)
3.2 Global Antihormonal Cancer Therapies Revenue Market Share by Manufacturers (2019-2024)
3.3 Antihormonal Cancer Therapies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Antihormonal Cancer Therapies Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Antihormonal Cancer Therapies Sales Sites, Area Served, Product Type
3.6 Antihormonal Cancer Therapies Market Competitive Situation and Trends
3.6.1 Antihormonal Cancer Therapies Market Concentration Rate
3.6.2 Global 5 and 10 Largest Antihormonal Cancer Therapies Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Antihormonal Cancer Therapies Industry Chain Analysis
4.1 Antihormonal Cancer Therapies Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Antihormonal Cancer Therapies Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Antihormonal Cancer Therapies Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Antihormonal Cancer Therapies Sales Market Share by Type (2019-2024)
6.3 Global Antihormonal Cancer Therapies Market Size Market Share by Type (2019-2024)
6.4 Global Antihormonal Cancer Therapies Price by Type (2019-2024)
7 Antihormonal Cancer Therapies Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Antihormonal Cancer Therapies Market Sales by Application (2019-2024)
7.3 Global Antihormonal Cancer Therapies Market Size (M USD) by Application (2019-2024)
7.4 Global Antihormonal Cancer Therapies Sales Growth Rate by Application (2019-2024)
8 Antihormonal Cancer Therapies Market Segmentation by Region
8.1 Global Antihormonal Cancer Therapies Sales by Region
8.1.1 Global Antihormonal Cancer Therapies Sales by Region
8.1.2 Global Antihormonal Cancer Therapies Sales Market Share by Region
8.2 North America
8.2.1 North America Antihormonal Cancer Therapies Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Antihormonal Cancer Therapies Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Antihormonal Cancer Therapies Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Antihormonal Cancer Therapies Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Antihormonal Cancer Therapies Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Roche
9.1.1 Roche Antihormonal Cancer Therapies Basic Information
9.1.2 Roche Antihormonal Cancer Therapies Product Overview
9.1.3 Roche Antihormonal Cancer Therapies Product Market Performance
9.1.4 Roche Business Overview
9.1.5 Roche Antihormonal Cancer Therapies SWOT Analysis
9.1.6 Roche Recent Developments
9.2 Amgen
9.2.1 Amgen Antihormonal Cancer Therapies Basic Information
9.2.2 Amgen Antihormonal Cancer Therapies Product Overview
9.2.3 Amgen Antihormonal Cancer Therapies Product Market Performance
9.2.4 Amgen Business Overview
9.2.5 Amgen Antihormonal Cancer Therapies SWOT Analysis
9.2.6 Amgen Recent Developments
9.3 Samyang Biopharmaceuticals
9.3.1 Samyang Biopharmaceuticals Antihormonal Cancer Therapies Basic Information
9.3.2 Samyang Biopharmaceuticals Antihormonal Cancer Therapies Product Overview
9.3.3 Samyang Biopharmaceuticals Antihormonal Cancer Therapies Product Market Performance
9.3.4 Samyang Biopharmaceuticals Antihormonal Cancer Therapies SWOT Analysis
9.3.5 Samyang Biopharmaceuticals Business Overview
9.3.6 Samyang Biopharmaceuticals Recent Developments
9.4 Tolmar
9.4.1 Tolmar Antihormonal Cancer Therapies Basic Information
9.4.2 Tolmar Antihormonal Cancer Therapies Product Overview
9.4.3 Tolmar Antihormonal Cancer Therapies Product Market Performance
9.4.4 Tolmar Business Overview
9.4.5 Tolmar Recent Developments
9.5 Bluebird Bio
9.5.1 Bluebird Bio Antihormonal Cancer Therapies Basic Information
9.5.2 Bluebird Bio Antihormonal Cancer Therapies Product Overview
9.5.3 Bluebird Bio Antihormonal Cancer Therapies Product Market Performance
9.5.4 Bluebird Bio Business Overview
9.5.5 Bluebird Bio Recent Developments
9.6 Bristol-Myers Squibb
9.6.1 Bristol-Myers Squibb Antihormonal Cancer Therapies Basic Information
9.6.2 Bristol-Myers Squibb Antihormonal Cancer Therapies Product Overview
9.6.3 Bristol-Myers Squibb Antihormonal Cancer Therapies Product Market Performance
9.6.4 Bristol-Myers Squibb Business Overview
9.6.5 Bristol-Myers Squibb Recent Developments
9.7 Exelixis
9.7.1 Exelixis Antihormonal Cancer Therapies Basic Information
9.7.2 Exelixis Antihormonal Cancer Therapies Product Overview
9.7.3 Exelixis Antihormonal Cancer Therapies Product Market Performance
9.7.4 Exelixis Business Overview
9.7.5 Exelixis Recent Developments
9.8 Guardant Health
9.8.1 Guardant Health Antihormonal Cancer Therapies Basic Information
9.8.2 Guardant Health Antihormonal Cancer Therapies Product Overview
9.8.3 Guardant Health Antihormonal Cancer Therapies Product Market Performance
9.8.4 Guardant Health Business Overview
9.8.5 Guardant Health Recent Developments
9.9 Illumina
9.9.1 Illumina Antihormonal Cancer Therapies Basic Information
9.9.2 Illumina Antihormonal Cancer Therapies Product Overview
9.9.3 Illumina Antihormonal Cancer Therapies Product Market Performance
9.9.4 Illumina Business Overview
9.9.5 Illumina Recent Developments
9.10 Novartis
9.10.1 Novartis Antihormonal Cancer Therapies Basic Information
9.10.2 Novartis Antihormonal Cancer Therapies Product Overview
9.10.3 Novartis Antihormonal Cancer Therapies Product Market Performance
9.10.4 Novartis Business Overview
9.10.5 Novartis Recent Developments
9.11 Merck KGaA
9.11.1 Merck KGaA Antihormonal Cancer Therapies Basic Information
9.11.2 Merck KGaA Antihormonal Cancer Therapies Product Overview
9.11.3 Merck KGaA Antihormonal Cancer Therapies Product Market Performance
9.11.4 Merck KGaA Business Overview
9.11.5 Merck KGaA Recent Developments
9.12 AbbVie
9.12.1 AbbVie Antihormonal Cancer Therapies Basic Information
9.12.2 AbbVie Antihormonal Cancer Therapies Product Overview
9.12.3 AbbVie Antihormonal Cancer Therapies Product Market Performance
9.12.4 AbbVie Business Overview
9.12.5 AbbVie Recent Developments
9.13 Gilead Sciences
9.13.1 Gilead Sciences Antihormonal Cancer Therapies Basic Information
9.13.2 Gilead Sciences Antihormonal Cancer Therapies Product Overview
9.13.3 Gilead Sciences Antihormonal Cancer Therapies Product Market Performance
9.13.4 Gilead Sciences Business Overview
9.13.5 Gilead Sciences Recent Developments
9.14 Johnson and Johnson
9.14.1 Johnson and Johnson Antihormonal Cancer Therapies Basic Information
9.14.2 Johnson and Johnson Antihormonal Cancer Therapies Product Overview
9.14.3 Johnson and Johnson Antihormonal Cancer Therapies Product Market Performance
9.14.4 Johnson and Johnson Business Overview
9.14.5 Johnson and Johnson Recent Developments
9.15 Pfizer
9.15.1 Pfizer Antihormonal Cancer Therapies Basic Information
9.15.2 Pfizer Antihormonal Cancer Therapies Product Overview
9.15.3 Pfizer Antihormonal Cancer Therapies Product Market Performance
9.15.4 Pfizer Business Overview
9.15.5 Pfizer Recent Developments
9.16 Takeda
9.16.1 Takeda Antihormonal Cancer Therapies Basic Information
9.16.2 Takeda Antihormonal Cancer Therapies Product Overview
9.16.3 Takeda Antihormonal Cancer Therapies Product Market Performance
9.16.4 Takeda Business Overview
9.16.5 Takeda Recent Developments
9.17 Eli Lilly
9.17.1 Eli Lilly Antihormonal Cancer Therapies Basic Information
9.17.2 Eli Lilly Antihormonal Cancer Therapies Product Overview
9.17.3 Eli Lilly Antihormonal Cancer Therapies Product Market Performance
9.17.4 Eli Lilly Business Overview
9.17.5 Eli Lilly Recent Developments
9.18 AstraZeneca
9.18.1 AstraZeneca Antihormonal Cancer Therapies Basic Information
9.18.2 AstraZeneca Antihormonal Cancer Therapies Product Overview
9.18.3 AstraZeneca Antihormonal Cancer Therapies Product Market Performance
9.18.4 AstraZeneca Business Overview
9.18.5 AstraZeneca Recent Developments
9.19 Astellas
9.19.1 Astellas Antihormonal Cancer Therapies Basic Information
9.19.2 Astellas Antihormonal Cancer Therapies Product Overview
9.19.3 Astellas Antihormonal Cancer Therapies Product Market Performance
9.19.4 Astellas Business Overview
9.19.5 Astellas Recent Developments
9.20 Merck and Co.
9.20.1 Merck and Co. Antihormonal Cancer Therapies Basic Information
9.20.2 Merck and Co. Antihormonal Cancer Therapies Product Overview
9.20.3 Merck and Co. Antihormonal Cancer Therapies Product Market Performance
9.20.4 Merck and Co. Business Overview
9.20.5 Merck and Co. Recent Developments
9.21 Sanofi
9.21.1 Sanofi Antihormonal Cancer Therapies Basic Information
9.21.2 Sanofi Antihormonal Cancer Therapies Product Overview
9.21.3 Sanofi Antihormonal Cancer Therapies Product Market Performance
9.21.4 Sanofi Business Overview
9.21.5 Sanofi Recent Developments
9.22 Bayer
9.22.1 Bayer Antihormonal Cancer Therapies Basic Information
9.22.2 Bayer Antihormonal Cancer Therapies Product Overview
9.22.3 Bayer Antihormonal Cancer Therapies Product Market Performance
9.22.4 Bayer Business Overview
9.22.5 Bayer Recent Developments
10 Antihormonal Cancer Therapies Market Forecast by Region
10.1 Global Antihormonal Cancer Therapies Market Size Forecast
10.2 Global Antihormonal Cancer Therapies Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Antihormonal Cancer Therapies Market Size Forecast by Country
10.2.3 Asia Pacific Antihormonal Cancer Therapies Market Size Forecast by Region
10.2.4 South America Antihormonal Cancer Therapies Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Antihormonal Cancer Therapies by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Antihormonal Cancer Therapies Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Antihormonal Cancer Therapies by Type (2025-2030)
11.1.2 Global Antihormonal Cancer Therapies Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Antihormonal Cancer Therapies by Type (2025-2030)
11.2 Global Antihormonal Cancer Therapies Market Forecast by Application (2025-2030)
11.2.1 Global Antihormonal Cancer Therapies Sales (K Units) Forecast by Application
11.2.2 Global Antihormonal Cancer Therapies Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Antihormonal Cancer Therapies Market Size Comparison by Region (M USD)
Table 5. Global Antihormonal Cancer Therapies Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Antihormonal Cancer Therapies Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Antihormonal Cancer Therapies Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Antihormonal Cancer Therapies Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antihormonal Cancer Therapies as of 2022)
Table 10. Global Market Antihormonal Cancer Therapies Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Antihormonal Cancer Therapies Sales Sites and Area Served
Table 12. Manufacturers Antihormonal Cancer Therapies Product Type
Table 13. Global Antihormonal Cancer Therapies Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Antihormonal Cancer Therapies
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Antihormonal Cancer Therapies Market Challenges
Table 22. Global Antihormonal Cancer Therapies Sales by Type (K Units)
Table 23. Global Antihormonal Cancer Therapies Market Size by Type (M USD)
Table 24. Global Antihormonal Cancer Therapies Sales (K Units) by Type (2019-2024)
Table 25. Global Antihormonal Cancer Therapies Sales Market Share by Type (2019-2024)
Table 26. Global Antihormonal Cancer Therapies Market Size (M USD) by Type (2019-2024)
Table 27. Global Antihormonal Cancer Therapies Market Size Share by Type (2019-2024)
Table 28. Global Antihormonal Cancer Therapies Price (USD/Unit) by Type (2019-2024)
Table 29. Global Antihormonal Cancer Therapies Sales (K Units) by Application
Table 30. Global Antihormonal Cancer Therapies Market Size by Application
Table 31. Global Antihormonal Cancer Therapies Sales by Application (2019-2024) & (K Units)
Table 32. Global Antihormonal Cancer Therapies Sales Market Share by Application (2019-2024)
Table 33. Global Antihormonal Cancer Therapies Sales by Application (2019-2024) & (M USD)
Table 34. Global Antihormonal Cancer Therapies Market Share by Application (2019-2024)
Table 35. Global Antihormonal Cancer Therapies Sales Growth Rate by Application (2019-2024)
Table 36. Global Antihormonal Cancer Therapies Sales by Region (2019-2024) & (K Units)
Table 37. Global Antihormonal Cancer Therapies Sales Market Share by Region (2019-2024)
Table 38. North America Antihormonal Cancer Therapies Sales by Country (2019-2024) & (K Units)
Table 39. Europe Antihormonal Cancer Therapies Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Antihormonal Cancer Therapies Sales by Region (2019-2024) & (K Units)
Table 41. South America Antihormonal Cancer Therapies Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Antihormonal Cancer Therapies Sales by Region (2019-2024) & (K Units)
Table 43. Roche Antihormonal Cancer Therapies Basic Information
Table 44. Roche Antihormonal Cancer Therapies Product Overview
Table 45. Roche Antihormonal Cancer Therapies Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Roche Business Overview
Table 47. Roche Antihormonal Cancer Therapies SWOT Analysis
Table 48. Roche Recent Developments
Table 49. Amgen Antihormonal Cancer Therapies Basic Information
Table 50. Amgen Antihormonal Cancer Therapies Product Overview
Table 51. Amgen Antihormonal Cancer Therapies Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Amgen Business Overview
Table 53. Amgen Antihormonal Cancer Therapies SWOT Analysis
Table 54. Amgen Recent Developments
Table 55. Samyang Biopharmaceuticals Antihormonal Cancer Therapies Basic Information
Table 56. Samyang Biopharmaceuticals Antihormonal Cancer Therapies Product Overview
Table 57. Samyang Biopharmaceuticals Antihormonal Cancer Therapies Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Samyang Biopharmaceuticals Antihormonal Cancer Therapies SWOT Analysis
Table 59. Samyang Biopharmaceuticals Business Overview
Table 60. Samyang Biopharmaceuticals Recent Developments
Table 61. Tolmar Antihormonal Cancer Therapies Basic Information
Table 62. Tolmar Antihormonal Cancer Therapies Product Overview
Table 63. Tolmar Antihormonal Cancer Therapies Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Tolmar Business Overview
Table 65. Tolmar Recent Developments
Table 66. Bluebird Bio Antihormonal Cancer Therapies Basic Information
Table 67. Bluebird Bio Antihormonal Cancer Therapies Product Overview
Table 68. Bluebird Bio Antihormonal Cancer Therapies Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Bluebird Bio Business Overview
Table 70. Bluebird Bio Recent Developments
Table 71. Bristol-Myers Squibb Antihormonal Cancer Therapies Basic Information
Table 72. Bristol-Myers Squibb Antihormonal Cancer Therapies Product Overview
Table 73. Bristol-Myers Squibb Antihormonal Cancer Therapies Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Bristol-Myers Squibb Business Overview
Table 75. Bristol-Myers Squibb Recent Developments
Table 76. Exelixis Antihormonal Cancer Therapies Basic Information
Table 77. Exelixis Antihormonal Cancer Therapies Product Overview
Table 78. Exelixis Antihormonal Cancer Therapies Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Exelixis Business Overview
Table 80. Exelixis Recent Developments
Table 81. Guardant Health Antihormonal Cancer Therapies Basic Information
Table 82. Guardant Health Antihormonal Cancer Therapies Product Overview
Table 83. Guardant Health Antihormonal Cancer Therapies Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Guardant Health Business Overview
Table 85. Guardant Health Recent Developments
Table 86. Illumina Antihormonal Cancer Therapies Basic Information
Table 87. Illumina Antihormonal Cancer Therapies Product Overview
Table 88. Illumina Antihormonal Cancer Therapies Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Illumina Business Overview
Table 90. Illumina Recent Developments
Table 91. Novartis Antihormonal Cancer Therapies Basic Information
Table 92. Novartis Antihormonal Cancer Therapies Product Overview
Table 93. Novartis Antihormonal Cancer Therapies Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Novartis Business Overview
Table 95. Novartis Recent Developments
Table 96. Merck KGaA Antihormonal Cancer Therapies Basic Information
Table 97. Merck KGaA Antihormonal Cancer Therapies Product Overview
Table 98. Merck KGaA Antihormonal Cancer Therapies Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Merck KGaA Business Overview
Table 100. Merck KGaA Recent Developments
Table 101. AbbVie Antihormonal Cancer Therapies Basic Information
Table 102. AbbVie Antihormonal Cancer Therapies Product Overview
Table 103. AbbVie Antihormonal Cancer Therapies Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. AbbVie Business Overview
Table 105. AbbVie Recent Developments
Table 106. Gilead Sciences Antihormonal Cancer Therapies Basic Information
Table 107. Gilead Sciences Antihormonal Cancer Therapies Product Overview
Table 108. Gilead Sciences Antihormonal Cancer Therapies Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Gilead Sciences Business Overview
Table 110. Gilead Sciences Recent Developments
Table 111. Johnson and Johnson Antihormonal Cancer Therapies Basic Information
Table 112. Johnson and Johnson Antihormonal Cancer Therapies Product Overview
Table 113. Johnson and Johnson Antihormonal Cancer Therapies Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. Johnson and Johnson Business Overview
Table 115. Johnson and Johnson Recent Developments
Table 116. Pfizer Antihormonal Cancer Therapies Basic Information
Table 117. Pfizer Antihormonal Cancer Therapies Product Overview
Table 118. Pfizer Antihormonal Cancer Therapies Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 119. Pfizer Business Overview
Table 120. Pfizer Recent Developments
Table 121. Takeda Antihormonal Cancer Therapies Basic Information
Table 122. Takeda Antihormonal Cancer Therapies Product Overview
Table 123. Takeda Antihormonal Cancer Therapies Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 124. Takeda Business Overview
Table 125. Takeda Recent Developments
Table 126. Eli Lilly Antihormonal Cancer Therapies Basic Information
Table 127. Eli Lilly Antihormonal Cancer Therapies Product Overview
Table 128. Eli Lilly Antihormonal Cancer Therapies Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 129. Eli Lilly Business Overview
Table 130. Eli Lilly Recent Developments
Table 131. AstraZeneca Antihormonal Cancer Therapies Basic Information
Table 132. AstraZeneca Antihormonal Cancer Therapies Product Overview
Table 133. AstraZeneca Antihormonal Cancer Therapies Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 134. AstraZeneca Business Overview
Table 135. AstraZeneca Recent Developments
Table 136. Astellas Antihormonal Cancer Therapies Basic Information
Table 137. Astellas Antihormonal Cancer Therapies Product Overview
Table 138. Astellas Antihormonal Cancer Therapies Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 139. Astellas Business Overview
Table 140. Astellas Recent Developments
Table 141. Merck and Co. Antihormonal Cancer Therapies Basic Information
Table 142. Merck and Co. Antihormonal Cancer Therapies Product Overview
Table 143. Merck and Co. Antihormonal Cancer Therapies Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 144. Merck and Co. Business Overview
Table 145. Merck and Co. Recent Developments
Table 146. Sanofi Antihormonal Cancer Therapies Basic Information
Table 147. Sanofi Antihormonal Cancer Therapies Product Overview
Table 148. Sanofi Antihormonal Cancer Therapies Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 149. Sanofi Business Overview
Table 150. Sanofi Recent Developments
Table 151. Bayer Antihormonal Cancer Therapies Basic Information
Table 152. Bayer Antihormonal Cancer Therapies Product Overview
Table 153. Bayer Antihormonal Cancer Therapies Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 154. Bayer Business Overview
Table 155. Bayer Recent Developments
Table 156. Global Antihormonal Cancer Therapies Sales Forecast by Region (2025-2030) & (K Units)
Table 157. Global Antihormonal Cancer Therapies Market Size Forecast by Region (2025-2030) & (M USD)
Table 158. North America Antihormonal Cancer Therapies Sales Forecast by Country (2025-2030) & (K Units)
Table 159. North America Antihormonal Cancer Therapies Market Size Forecast by Country (2025-2030) & (M USD)
Table 160. Europe Antihormonal Cancer Therapies Sales Forecast by Country (2025-2030) & (K Units)
Table 161. Europe Antihormonal Cancer Therapies Market Size Forecast by Country (2025-2030) & (M USD)
Table 162. Asia Pacific Antihormonal Cancer Therapies Sales Forecast by Region (2025-2030) & (K Units)
Table 163. Asia Pacific Antihormonal Cancer Therapies Market Size Forecast by Region (2025-2030) & (M USD)
Table 164. South America Antihormonal Cancer Therapies Sales Forecast by Country (2025-2030) & (K Units)
Table 165. South America Antihormonal Cancer Therapies Market Size Forecast by Country (2025-2030) & (M USD)
Table 166. Middle East and Africa Antihormonal Cancer Therapies Consumption Forecast by Country (2025-2030) & (Units)
Table 167. Middle East and Africa Antihormonal Cancer Therapies Market Size Forecast by Country (2025-2030) & (M USD)
Table 168. Global Antihormonal Cancer Therapies Sales Forecast by Type (2025-2030) & (K Units)
Table 169. Global Antihormonal Cancer Therapies Market Size Forecast by Type (2025-2030) & (M USD)
Table 170. Global Antihormonal Cancer Therapies Price Forecast by Type (2025-2030) & (USD/Unit)
Table 171. Global Antihormonal Cancer Therapies Sales (K Units) Forecast by Application (2025-2030)
Table 172. Global Antihormonal Cancer Therapies Market Size Forecast by Application (2025-2030) & (M USD)
List of Figures
Figure 1. Product Picture of Antihormonal Cancer Therapies
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Antihormonal Cancer Therapies Market Size (M USD), 2019-2030
Figure 5. Global Antihormonal Cancer Therapies Market Size (M USD) (2019-2030)
Figure 6. Global Antihormonal Cancer Therapies Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Antihormonal Cancer Therapies Market Size by Country (M USD)
Figure 11. Antihormonal Cancer Therapies Sales Share by Manufacturers in 2023
Figure 12. Global Antihormonal Cancer Therapies Revenue Share by Manufacturers in 2023
Figure 13. Antihormonal Cancer Therapies Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Antihormonal Cancer Therapies Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Antihormonal Cancer Therapies Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Antihormonal Cancer Therapies Market Share by Type
Figure 18. Sales Market Share of Antihormonal Cancer Therapies by Type (2019-2024)
Figure 19. Sales Market Share of Antihormonal Cancer Therapies by Type in 2023
Figure 20. Market Size Share of Antihormonal Cancer Therapies by Type (2019-2024)
Figure 21. Market Size Market Share of Antihormonal Cancer Therapies by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Antihormonal Cancer Therapies Market Share by Application
Figure 24. Global Antihormonal Cancer Therapies Sales Market Share by Application (2019-2024)
Figure 25. Global Antihormonal Cancer Therapies Sales Market Share by Application in 2023
Figure 26. Global Antihormonal Cancer Therapies Market Share by Application (2019-2024)
Figure 27. Global Antihormonal Cancer Therapies Market Share by Application in 2023
Figure 28. Global Antihormonal Cancer Therapies Sales Growth Rate by Application (2019-2024)
Figure 29. Global Antihormonal Cancer Therapies Sales Market Share by Region (2019-2024)
Figure 30. North America Antihormonal Cancer Therapies Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Antihormonal Cancer Therapies Sales Market Share by Country in 2023
Figure 32. U.S. Antihormonal Cancer Therapies Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Antihormonal Cancer Therapies Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Antihormonal Cancer Therapies Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Antihormonal Cancer Therapies Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Antihormonal Cancer Therapies Sales Market Share by Country in 2023
Figure 37. Germany Antihormonal Cancer Therapies Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Antihormonal Cancer Therapies Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Antihormonal Cancer Therapies Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Antihormonal Cancer Therapies Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Antihormonal Cancer Therapies Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Antihormonal Cancer Therapies Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Antihormonal Cancer Therapies Sales Market Share by Region in 2023
Figure 44. China Antihormonal Cancer Therapies Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Antihormonal Cancer Therapies Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Antihormonal Cancer Therapies Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Antihormonal Cancer Therapies Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Antihormonal Cancer Therapies Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Antihormonal Cancer Therapies Sales and Growth Rate (K Units)
Figure 50. South America Antihormonal Cancer Therapies Sales Market Share by Country in 2023
Figure 51. Brazil Antihormonal Cancer Therapies Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Antihormonal Cancer Therapies Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Antihormonal Cancer Therapies Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Antihormonal Cancer Therapies Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Antihormonal Cancer Therapies Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Antihormonal Cancer Therapies Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Antihormonal Cancer Therapies Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Antihormonal Cancer Therapies Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Antihormonal Cancer Therapies Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Antihormonal Cancer Therapies Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Antihormonal Cancer Therapies Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Antihormonal Cancer Therapies Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Antihormonal Cancer Therapies Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Antihormonal Cancer Therapies Market Share Forecast by Type (2025-2030)
Figure 65. Global Antihormonal Cancer Therapies Sales Forecast by Application (2025-2030)
Figure 66. Global Antihormonal Cancer Therapies Market Share Forecast by Application (2025-2030)
